Craig-Hallum Initiates Coverage On TELA Bio with Buy Rating, Announces Price Target of $2
9/25/2026
Impact: 70
Healthcare
Craig-Hallum analyst Chase Knickerbocker has initiated coverage on TELA Bio (NASDAQ: TELA) with a Buy rating. The analyst has set a price target of $2 for the company's stock.
AI summary, not financial advice
Share: